Riding Out Rejection

How to navigate the choppy waters of scientific publication

Written byKate Yandell
| 9 min read
riding out rejection publishing

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

© ISTOCK.COM/WRAGGIn July 2012, while attending the 12th International Coral Reef Symposium in Cairns, Australia, Emily Darling received a heart-wrenching e-mail: Ecology Letters had rejected her paper on coral life histories. She was shocked. The paper had already gone through one very positive round of reviews, and Darling, then in the final months of her PhD program at Simon Fraser University outside Vancouver, Canada, had resubmitted it with the requested changes. Just the day before, a senior colleague at a cocktail hour had revealed to her that he was one of the reviewers and that he had recommended that the journal publish her paper. Another reviewer had clearly disagreed.

“It felt like the worst place in the world that I ever could have got the rejection,” says Darling, who received the e-mail in a conference room full of her peers. “I’m looking around at this amphitheater of people and saying, ‘Who did it?’ It sort of personalized the rejection experience.”

But Darling’s advisor, Isabelle Côté, wasn’t about to take the rejection without a fight. The pair tracked down the paper’s editor, who was also at the conference, and learned that the negative reviewer had been added in the second round because two first-round reviewers had been unavailable. Darling and Côté asked the editor if he would consider a letter rebutting the negative reviewer’s criticisms, then tracked down the positive reviewer Darling had met, who ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies